Anish Patel
Vermögen: 13 Mio $ am 31.07.2026
Vermögen: 13 Mio $ am 31.07.2026
Anish Patel is the founder of Enliven Therapeutics, Inc., founded in 2019, and holds the title of Chief Operating Officer since 2023.
Dr. Patel is also the founder of Enliven Therapeutics, Inc...
Dr. Patel worked at AbbVie Stemcentrx LLC from 2013 to 2016 as Senior Director-Field Medical & Marketing.
Dr. Patel worked at Stemcentrx, Inc. from 2016 to 2019 as Head-Medical Affairs.
Dr. Patel earned a doctorate from the University of Michigan and completed undergraduate studies at the University of Illinois At Urbana–Champaign.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.02.2026 | 235.011 ( 0,33 % ) | 13 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ENLIVEN THERAPEUTICS, INC. | Gründer | 01.06.2019 |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Gründer | - |
| Unternehmen | Position | Ende |
|---|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Corporate Officer/Principal | 01.04.2019 |
AbbVie Stemcentrx LLC | Vertrieb & Marketing | 01.07.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Stemcentrx, Inc.
Stemcentrx, Inc. BiotechnologyHealth Technology Develops life-changing therapies for cancer patients | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie Stemcentrx LLC | |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology Engages in discovery and development of small molecule treatments for cancer | Health Technology |
Enliven Therapeutics, Inc.
Enliven Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage precision oncology company that develops molecule therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen